H B. Kuiperij
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Incidental DWI-Positive Lesions in 2 Cohorts of CAA and CADASIL: Prevalence, Distribution, and Associations With Clinical Variables.
Journal: Neurology
Published: June 26, 2026
Evaluating Basigin as a Potential Biomarker of Blood-Brain Barrier Dysfunction in Cerebral Amyloid Angiopathy.
Journal: Neuropathology and applied neurobiology
Published: September 10, 2025
The relationship between CSF/serum immunoglobulin and albumin ratio across laboratories: a retrospective, multi-center study.
Journal: Fluids and barriers of the CNS
Published: April 03, 2025
Correction: Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid angiopathy.
Journal: Alzheimer's research & therapy
Published: July 06, 2024
No replicating evidence for anti-amyloid-β autoantibodies in cerebral amyloid angiopathy-related inflammation.
Journal: Annals of clinical and translational neurology
Published: May 31, 2024
Altered brain expression and cerebrospinal fluid levels of TIMP4 in cerebral amyloid angiopathy.
Journal: Acta neuropathologica communications
Published: April 19, 2024
Decreased microvascular claudin-5 levels in cerebral amyloid angiopathy associated with intracerebral haemorrhage.
Journal: Brain pathology (Zurich, Switzerland)
Published: January 30, 2024
The relation of a cerebrospinal fluid profile associated with Alzheimer's disease with cognitive function and neuropsychiatric symptoms in sporadic cerebral amyloid angiopathy.
Journal: Alzheimer's research & therapy
Published: January 26, 2024
Proximity extension assay in cerebrospinal fluid identifies neurofilament light chain as biomarker of neurodegeneration in sporadic cerebral amyloid angiopathy.
Journal: Alzheimer's research & therapy
Published: December 21, 2023
Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid Angiopathy.
Journal: Alzheimer's research & therapy
Published: November 29, 2023
Profiling amyloid-β peptides as biomarkers for cerebral amyloid angiopathy.
Journal: Journal of neurochemistry
Published: October 25, 2023
Last Updated: 09/26/2026